Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
Two types of vaccines for preventing and treating allergic diseases including atopic dermatitis, allergic asthma, allergic rhinitis, allergic conjunctivitis, and urticaria. More
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Related Reports
Market Research Reports provided by reports.iptechex.com
Dec 2010 - $15,200
Apr 2011 - 45 pages - $3,800
Jul 2010 - 46 pages - $2,000
Feb 2011 - 92 pages - $500
Jul 2011 - 57 pages - $3,800
Nov 2010 - 63 pages - $1,000
Mar 2011 - 46 pages - $3,800
Aug 2011 - 8 pages - $75
Jun 2011 - 146 pages - $11,400
Sep 2011 - 98 pages - $500
Your selection
Browse By
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us